Shu-Wen Teng

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Systematic Review

Small Cell Lung Cancer

Top Venues

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology (2023)
Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Yucheng Sheng, Shu-Wen Teng, Jingru Wang, Hao Wang, Archie N Tse
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)